Protocol No
PULM-GOSSAMER-PROSERA
Staff Member
Kenneth Presberg
Phase
III
Summary
This project is being done to study the effects and safety of the oral inhalation of seralutinib for the treatment of PAH.
Objective
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov